Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Biomarkers of neurodegeneration and neuronal injury have the potential to improve diagnostic accuracy, disease monitoring, prognosis, and measure treatment efficacy. Neurofilament proteins (NfPs) are well suited as biomarkers in these contexts because they are major neuron-specific components that m...
Main Authors: | Aidong Yuan, Ralph A. Nixon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.689938/full |
Similar Items
-
Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
by: Delia Gagliardi, et al.
Published: (2019-08-01) -
CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy
by: Robert Daniel Nass, et al.
Published: (2021-04-01) -
CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
by: Qionghua Sun, et al.
Published: (2020-08-01) -
Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
by: Marie Dreger, et al.
Published: (2021-04-01) -
The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)